ATR inhibitor 2 is an ATP-competitive, orally active, and selective ATR inhibitor, with a Ki of <150 pM. ATR inhibitor 2 potently inhibits ATR-driven phosphorylated checkpoint kinase-1 (Chk1) phosphorylation with an IC50 of 8 nM. Antitumor activity[1][2].
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | ATM ↓ ↑ | ATR ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wortmannin |
++
ATM, IC50: 150 nM |
MLCK,DNA-PK,PI3K | 99%+ | ||||||||||||||||
CP-466722 |
+
ATM, IC50: 410 nM |
99%+ | |||||||||||||||||
Torin 2 |
++
ATM, EC50: 28 nM |
++
ATR, EC50: 35 nM |
mTOR,DNA-PK | 99%+ | |||||||||||||||
KU-55933 |
+++
ATM, IC50: 12.9 nM |
96% | |||||||||||||||||
ETP-46464 |
+
ATM, IC50: 545 nM |
+++
ATR, IC50: 14 nM |
mTOR,DNA-PK | 98% | |||||||||||||||
CGK733 |
++
ATM, IC50: 200 nM |
++
ATR, IC50: 200 nM |
99%+ | ||||||||||||||||
AZD0156 | ✔ | 99%+ | |||||||||||||||||
Dactolisib |
+++
ATR, IC50: 21 nM |
98+% | |||||||||||||||||
Ceralasertib |
++++
ATR, IC50: 1 nM |
99%+ | |||||||||||||||||
Berzosertib |
+++
ATR, IC50: 19 nM |
99%+ | |||||||||||||||||
VE-821 |
+++
ATR, Ki: 13 nM |
99%+ | |||||||||||||||||
AZ20 |
++++
ATR, IC50: 5 nM |
mTOR | 99%+ | ||||||||||||||||
Schizandrin B |
+
ATR, IC50: 7.25 μM |
P-gp | 98% | ||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
描述 | Gartisertib (VX-803) is an orally active, ATP-competitive, and selective inhibitor of ATR, with a Ki value of <150 pM. It effectively suppresses ATR-driven phosphorylation of checkpoint kinase-1 (Chk1) with an IC50 of 8 nM. It also demonstrates significant antitumor activity [1][2]. |
体内研究 | In efficacy studies as a monotherapy, Gartisertib demonstrates tumor stasis to regression in tumor models characterized by alternative lengthening of telomeres (ALT). When combined with PARP inhibitors, tumor regression is observed in xenograft models of triple-negative breast cancer [1]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.85mL 0.37mL 0.18mL |
9.23mL 1.85mL 0.92mL |
18.47mL 3.69mL 1.85mL |
CAS号 | 1613191-99-3 |
分子式 | C25H29F2N9O3 |
分子量 | 541.553 |
别名 | VX-803;M4344;Gartisertibum;ATR inhibitor 2 |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Keep in dark place,Inert atmosphere,Store in freezer, under -20°C |
溶解度 |
DMSO: 25 mg/mL(46.16 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |